Evofem Biosciences, Inc., (NASDAQ: EVFM) Featured in Virtual Coverage of LD Micro’s Invitational XI
Evofem Biosciences, Inc., (NASDAQ: EVFM)is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company launched its first FDA-approved commercial product, Phexxi® (lactic acid, citric acid and potassium bitartrate), in the U.S. in September 2020. It plans to commercialize Phexxi in foreign markets through partnerships. Top line results are expected in Q2 2022…